DERIVATE VON 1-AMINO-2-CYCLOPROPYLETHYLBORONSÄURE

Patent europeic · EP2552216 · Stritgà

Inscripziun en il register

Numer da publicaziun
EP2552216
Numer da la dumonda
EP11763354
Gener
Patent europeic cun effect per la Svizra ed il Liechtenstein
Status
Stritgà
Scrittira da patent
Concedì
Annunzià
30-03-2011
Publitgà
06-02-2013
Concedì
24-01-2018
Stritgà
31-03-2020
Motiv
Taxa annuala betg pajada
Classas IPC
A61K 31/69 (2006.01)
A61P 35/00 (2006.01)
C07F 5/02 (2006.01)
Prioritad
US 319464 P 31.03.2010
Dumonda PCT
PCT/US2011/030455 30.03.2011
Publicaziun PCT
WO2011/123502 06.10.2011
Lingua da l’annunzia
englais
Funtauna
Swissreg

Istorgia

Quai che l’Institut federal da la proprietad intellectuala ha publitgà davart quest titel, il pli nov l’emprim.

  1. 21-10-2020

    Stritgà, taxa betg pajada

    Published in Swissreg on 21.10.2020

  2. 24-01-2018

    Concedì

    Published in Swissreg on 24.01.2018

Partidas

Possessur

Millennium Pharmaceuticals, Inc.

40 Landsdowne Street, Cambridge, MA 02139, US

Inventur

FLEMING, Paul, E.

Weston, MA 02493, US

LI, Jing

Lansdale, PA 19446, US

Il register numna mintga partida cun num ed adressa. In possessur u in represchentant vegn collià cun in’organisaziun, sch’exact ina unitad giuridica dal register da commerzi porta ses num; la via d’ina partida betg enconuschida uschia na vegn betg mussada qua.